Postmenopausal osteoporosis (PMOP) is a prevalent skeletal disorder associated with
menopause-related estrogen withdrawal. PMOP is characterized by low bone mass …

Hydroxyapatite possesses desirable properties as a scaffold in tissue engineering: it is
biocompatible at a site of implantation, and it is degradable to non-toxic products. Moreover …

Ossification of the posterior longitudinal ligament (OPLL) is an emerging spinal disease
caused by heterotopic ossification of the posterior longitudinal ligament. The pathological …

Bone mass is determined by the balance between bone formation, carried out by
mesenchymal stem cell-derived osteoblasts, and bone resorption, carried out by monocyte …

Corylin is a naturally occurring flavonoid isolated from the fruit of Psoralea corylifolia
L.(Fabaceae), which is a Chinese medicinal herb in treating osteoporosis. Although a variety …

Mesenchymal stem cells (MSCs) are multipotent stromal cells that are identified by in vitro
plastic adherence, colony-forming capacity, expression of a panel of surface molecules, and …

Mesenchymal stem/stromal cells (MSCs) have emerged as a promising tool in the field of
regenerative medicine due to their unique therapeutic properties as they can differentiate …

Osteoporosis (OP), a common systemic metabolic bone disease, is characterized by low
bone mass, increasing bone fragility and a high risk of fracture. At present, the clinical …

Decline of pluripotency in bone marrow stromal cells (BMSCs) associated with estrogen
deficiency leads to a bone formation defect in osteoporosis. Special AT‐rich sequence …

Fracture healing is a well-orchestrated and coordinated process and begins with the
inflammatory stage involving the infiltration of immune cells and the release of cytokines …